Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Hong-Ming Hu | M | - |
UbiVac, Inc.
 UbiVac, Inc. Pharmaceuticals: MajorHealth Technology UbiVac LLC engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases. The company was founded by Bernard A. Fox and Hong-Ming Hu in 2005 and is headquartered in Portland, OR. | 19 Jahre |
| Michael C. Phillips | M | - |
Oregon Bioscience Association
 Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Anthony Maida | M | 59 |
International Society for Biological Therapy of Cancer
 International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Liisa Bozinovic | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Heather Ellis | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Lisa Butterfield | F | - |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Tina Guldberg | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Todd Predmore | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Lisa Hale | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Peter Barr-Gillespie | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Richard Glassman | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Juergen Lindner | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Soundharya Nagasubramanian | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Brenna Rauw | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Tim Brown | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Nancy Lime | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| David Kaufman | M | 51 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Bernard A. Fox | M | - |
UbiVac, Inc.
UbiVac, Inc. Pharmaceuticals: MajorHealth Technology UbiVac LLC engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases. The company was founded by Bernard A. Fox and Hong-Ming Hu in 2005 and is headquartered in Portland, OR. | 19 Jahre |
| Ralph Makar | M | 63 |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Daniel S. Chen | M | 55 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | 6 Jahre |
| Steven J. Prewitt | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Sean McClain | M | 34 |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | 5 Jahre |
| Abraham Mittelman | M | 75 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Jon Wigginton | M | 62 |
UbiVac, Inc.
UbiVac, Inc. Pharmaceuticals: MajorHealth Technology UbiVac LLC engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases. The company was founded by Bernard A. Fox and Hong-Ming Hu in 2005 and is headquartered in Portland, OR. | 4 Jahre |
| James Matteucci | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Dan Snyder | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | 3 Jahre |
| Jessica Flechtner | M | 52 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Alessandra Cesano | M | 63 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | - |
| Sandra Lee Shotwell | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | 5 Jahre |
| Adrian Polliack | M | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
| Denise McCarty | F | - |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Martin K. McCarthy | M | 65 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL.
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 5 Jahre |
| Michael L. Babich | M | 47 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 8 Jahre |
| Steven J. Meyer | M | 67 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 12 Jahre |
| Laurence P. Birch | M | 64 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 4 Jahre |
| Paul Freiman | M | 89 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL.
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 7 Jahre |
| Frank C. Becker | M | 88 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL.
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 7 Jahre |
| Pierre LaPalme | M | 83 | 9 Jahre | |
| Guillermo A. Herrera | M | 70 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 2 Jahre |
| Jon McGarity | M | 81 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 1 Jahre |
| Brian Tambi | M | 78 | - | |
| Acquilar Rahman | M | - |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 21 Jahre |
| Lawrence Kenyon | M | 58 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 6 Jahre |
| Ronald E. Pauli | M | 63 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 1 Jahre |
| Shahid Ali | M | - |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 10 Jahre |
| John N. Kapoor | M | 80 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 21 Jahre |
| Richard Mallery | M | 86 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | - |
| Ramesh Acharya | M | - |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | - |
| Ellen Feigal | M | 69 | 1 Jahre | |
| Aquilur Rahman | M | - | - | |
| Troy Ignelzi | M | 56 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 2 Jahre |
| Imran Ahmad | M | 59 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 6 Jahre |
| Jeffrey Sherman | M | 69 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 7 Jahre |
| Kaveh T. Safavi | M | - |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | - |
| Erick E. Hanson | M | 77 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 10 Jahre |
| Patrick P. Fourteau | M | 77 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | 4 Jahre |
| Timothy Charles Melkus | M | 65 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 1 Jahre |
| Larry Dillaha | M | 60 | 4 Jahre | |
| Timothy Walbert | M | 57 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 1 Jahre |
| Steven B. Binion | M | 71 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | - |
| Ronald G. Eidell | M | 80 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | - |
| Gregory P. Young | M | 70 |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | 1 Jahre |
| Zafeer Ahmad | M | - |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 63 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Bernard A. Fox
- Persönliches Netzwerk
